Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RPRX
#500
Royalty Pharma plc Class A Ordinary Shares
46.210
0
+2.45%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+2.45%
Mudança mensal
+13.99%
Mudança em 6 meses
+24.02%
Mudança anual
+24.02%
Fechamento anterior
45.105
0
Open
46.210
0
Bid
Ask
Low
46.210
0
High
46.210
0
Volume
225
Mercados
Ações
Cuidados de saúde
RPRX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
388.13 M
432.96 M
443.17 M
446.69 M
433.32 M
428.42 M
—
Valuation ratios
Enterprise value
303.91 T
242 T
239.29 T
168.93 T
147.08 T
222.94 T
811.84 T
Price to earnings ratio
31.16
39.04
394
11.17
13.36
21.71
70.31
Price to sales ratio
8.85
7.22
7.71
7.24
6.7
9.17
34.98
Price to cash flow ratio
14.93
11.99
8.05
5.7
5.47
8.76
32.76
Price to book ratio
6.31
4.19
3.07
2.61
2.18
3.37
5.6
Enterprise value to EBITDA ratio
168.52 K
113.31 K
577.4 K
109.36 K
120.6 K
150.62 K
509.31 K
Profitability ratios
Return on assets %
0.06
0.04
0
0.07
0.05
0.04
0.04
Return on equity %
0.1
0.06
0
0.11
0.08
0.08
0.08
Return on invested capital %
45.75
39.11
7.99
38.15
30.83
34.06
34.9
Gross margin %
92.64
99.44
50.92
75.24
63.21
86.46
343.51
Operating margin %
75.17
62.49
13.73
63.37
57.1
65.58
262.81
EBITDA margin %
84.97
93.29
18.52
65.6
53.88
62.24
248.14
Net margin %
45.94
27.07
1.91
48.2
37.95
32.42
128.9
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.76
16.81
2.19
7.9
1.44
2.4
8.7
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.13
0.14
0.13
0.14
0.13
0.13
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.36
0.41
0.36
0.37
0.36
0.44
1.64
Long term debt to total equity ratio
1.21
1.23
1.09
0.94
0.95
1.32
4.75
Per share metrics
Operating cash flow per share
3.35
3.32
4.9
4.96
4.66
4.41
4.4
EBIT per share
2.91
3.45
0.88
2.53
2.02
2.58
2.59
EBITDA per share
2.97
3.52
0.95
2.56
2.05
2.62
2.63
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.4
3.61
3.96
0.82
1.66
1.13
5.89
Net current asset value per share
4.44
4.74
5.83
2.11
3.03
2.71
11.9
Tangible book value per share
12.76
13.91
12.85
10.83
11.69
9.84
40.86
Working capital per share
3.94
4.46
3.17
1.85
0.92
1.58
5.64
Book value per share
7.94
9.51
12.85
10.83
11.69
11.47
45.8
Notícias
TD Cowen eleva preço-alvo das ações da Royalty Pharma para US$ 50 com base no crescimento
TD Cowen raises Royalty Pharma stock price target to $50 on growth
Ações da Royalty Pharma atingem máxima de 52 semanas a US$ 46,14
Royalty Pharma stock hits 52-week high at 46.14 USD
Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
BofA Securities mantém recomendação de compra para ações da Royalty Pharma com preço-alvo de US$ 54
Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript
Ação da AnaptysBio atinge máxima de 52 semanas a US$ 52,56
Ações da Royalty Pharma atingem máxima de 52 semanas a US$ 44,94
Royalty Pharma stock hits 52-week high at 44.94 USD